Müller, E <br/><br/>
Pan-Raf co-operates with PI3K-dependent signalling and critically contributes to myeloma cell survival independently of mutated RAS.  [electronic resource] 

 -  Leukemia  04 2017 
 - 922-933 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/leu.2016.264  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--genetics<br/>Cell Line, Tumor<br/>Cell Survival--genetics<br/>Drug Resistance, Neoplasm<br/>Enzyme Activation<br/>Gene Expression<br/>Gene Knockdown Techniques<br/>Humans<br/>Isoenzymes<br/>Lenalidomide<br/>MAP Kinase Signaling System--drug effects<br/>Multiple Myeloma--genetics<br/>Mutation<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Phosphorylation--drug effects<br/>Protein Binding<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins B-raf--antagonists & inhibitors<br/>RNA Interference<br/>RNA, Small Interfering--genetics<br/>Signal Transduction<br/>TOR Serine-Threonine Kinases--metabolism<br/>Thalidomide--analogs & derivatives<br/>ras Proteins--genetics